| Literature DB >> 32616745 |
Caroline J Shaw1,2, Kimberley J Botting1,3, Youguo Niu1,3, Christoph C Lees2,4, Dino A Giussani5,6.
Abstract
A cohort study of 6,500,000 human pregnancies showed an increased risk of adverse fetal outcomes following abdominal but not non-abdominal surgery under general anesthesia. This may be the consequence of uterine handling during abdominal surgery. However, there are no data on any effects on the cardiometabolic physiology of the fetus or mother in response to uterine manipulation in otherwise healthy pregnancy. Consequently, 9 sheep in late gestation were anesthetized with isofluorane and maternal and fetal catheters and flow probes were implanted to determine cardiovascular and metabolic changes during uterine handling. Uterine handling led to an acute increase in uterine artery vascular resistance, fetal peripheral vasoconstriction, a reduction in oxygen delivery to the femoral circulation, worsening fetal acidosis. There was no evidence of systemic fetal hypoxia, or changes in fetal heart rate, carotid blood flow or carotid oxygen delivery. Therefore, the data support that uterine handling during abdominal surgery under general anesthesia can impact adversely on fetal cardiometabolic health. This may provide a potential explanation linking adverse fetal outcomes in abdominal compared with non-abdominal surgery during pregnancy. The data have important implications for human fetal surgery where the uterus is handled, as operative procedures during late gestation under general maternal anesthesia become more prevalent.Entities:
Mesh:
Year: 2020 PMID: 32616745 PMCID: PMC7331497 DOI: 10.1038/s41598-020-67714-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Maternal cardiovascular responses to uterine manipulation. The graph shows mean values for each sequential minute ± SEM (n = 9) of percentage change from baseline (− 30 to 0 min) period. The dashed box (0–30 min) denotes the period of uterine handling. The recovery period is 30–60 min. The black bar shows the timing of significant change from baseline, assessed using a repeated measure one-way ANOVA with post hoc Bonferroni test. The P value shown on the graph is the overall significance of the RM ANOVA with Glasshouse–Geisser correction for the effect of time.
Figure 2Fetal cardiovascular responses to uterine manipulation. The graph shows mean values for each sequential minute ± SEM (n = 9) of percentage change from the baseline (− 30 to 0 min) period. The dashed box (0–30 min) denotes the period of uterine handling. The recovery period is 30–60 min. The black bar shows the timing of significant change from baseline, assessed using a repeated measure one-way ANOVA with post hoc Bonferroni test. The P value shown on the graph is the overall significance of the RM ANOVA with Glasshouse–Geisser correction for the effect of time.
Maternal arterial acid–base and metabolic status.
| Variable | Baseline | Uterine handling | Recovery | |||
|---|---|---|---|---|---|---|
| ( −30 min) | (0 min) | (15 min) | (30 min) | (60 min) | ||
| pH | 7.40 ± 0.02 | 7.40 ± 0.02 | 7.39 ± 0.02 | 7.37 ± 0.02* | 7.37 ± 0.02* | 0.009 |
| PaCO2 (mmHg) | 51.6 ± 3.2 | 53.9 ± 4.2 | 57.4 ± 3.6* | 59.3 ± 3.9* | 59.0 ± 3.9* | < 0.001 |
| PaO2 (mmHg) | 202 ± 23 | 182 ± 20 | 168 ± 21 | 178 ± 25 | 174 ± 22 | 0.60 |
| Oxyhemoglobin saturation (%) | 102 ± 1 | 102 ± 1 | 102 ± 1 | 102 ± 1 | 102 ± 1 | 0.90 |
| Arterial base excess (mmol l−1) | 5.7 ± 1.6 | 6.3 ± 1.1 | 5.3 ± 0.9 | 6.0 ± 1.0 | 5.4 ± 1.1 | 0.70 |
| Bicarbonate (mEq L−1) | 31.7 ± 1.5 | 32.4 ± 1.3 | 32.4 ± 1.3 | 32.3 ± 1.2 | 31.4 ± 1.1 | 0.57 |
| Lactate (mmol l−1) | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.09 |
| Hemoglobin (g d l−1) | 8.9 ± 0.6 | 9.0 ± 0.5 | 9.1 ± 0.5 | 9.6 ± 0.3 | 9.7 ± 0.4* | 0.04 |
| Hematocrit (%) | 24 ± 1 | 24 ± 1 | 25 ± 1 | 28 ± 1* | 0.04 | |
Values represent mean ± SEM for n = 9 of maternal femoral arterial blood samples at the start (“− 30”) and end (“0”) of the baseline period; the midpoint (“15”) and end (“30”) of the period of uterine handling and the end of the recovery period (“60”). Significant differences are: *P < 0.05, for each timepoint when compared to timepoint “− 30”, assessed using a repeated-measures (RM) one-way ANOVA with post hoc Bonferroni test. The P value quoted in the final column is the overall significance of the RM ANOVA with Glasshouse–Geisser correction for the effect of time.
Figure 3Fetal arterial acid–base and metabolic status. Values represent mean ± SEM of n = 9 for fetal carotid (open circles) and femoral (closed circles) arterial blood samples at the start (“− 30”) and end (“0”) of the baseline period; the midpoint (“15”) and end (“30”) of the period of uterine handling and the end of the recovery period (“60”). Significant differences are: *P < 0.05, for each timepoint when compared to timepoint “− 30”, assessed using a repeated-measures (RM) one-way ANOVA with post hoc Bonferroni test. The P value quoted in the final column is the overall significance of the RM ANOVA with Glasshouse–Geisser correction for the effect of time.
Fetal oxygen delivery to pre and post ductal circulations.
| Variable | Baseline | Uterine handling | Recovery | |||
|---|---|---|---|---|---|---|
| (− 30 min) | (0 min) | (15 min) | (30 min) | (60 min) | ||
| Carotid oxygen delivery (mmol min−1) | 337 ± 57 | 340 ± 35 | 300 ± 27 | 309 ± 36 | 251 ± 27 | 0.21 |
| Femoral oxygen delivery (mmol min−1) | 102 ± 14 | 106 ± 15 | 73 ± 11* | 86 ± 13 | 77 ± 17 | 0.01 |
Values represent mean ± SEM for n = 9 of fetal carotid and femoral arterial oxygen delivery calculated at the start (“− 30”) and end (“0”) of the baseline period; the midpoint (“15”) and end (“30”) of the period of uterine handling and the end of the recovery period (“60”). Significant differences are: *P < 0.05, for each timepoint when compared to timepoint “− 30”, assessed using a repeated-measures (RM) one-way ANOVA with post hoc Bonferroni test. The P value quoted in the final column is the overall significance of the RM ANOVA with Glasshouse–Geisser correction for the effect of time.